An investigation for investors in Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) shares over potential securities laws violations by Verrica Pharmaceuticals Inc. was announced.

San Diego, CA -- (SBWire) -- 06/06/2022 --Verrica Pharmaceuticals Inc is under investigation over potential securities laws violations in connection with certain financial statements.

Investors who purchased shares of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Verrica Pharmaceuticals Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

West Chester, PA based Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. On May 24, 2022, after the market closed, Verrica Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration ("FDA") had issued a Complete Response Letter regarding its New Drug Application for molluscum contagiosum treatment, VP-102. Specifically, the FDA cited "deficiencies identified at a general reinspection of Sterling Pharmaceuticals Services, LLC (Sterling), the contract manufacturing organization (CMO) that manufactures Verrica's bulk solution drug product."

Shares of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) declined from $9.22 per share on April 7, 2022, to as low as $1.77 per share on June 1, 2022.

Those who purchased shares of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.